Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

When was fasenra approved?

See the DrugPatentWatch profile for fasenra

When was Fasenra (benralizumab) approved?

Fasenra (benralizumab) was approved in the United States in 2017.[1]

Was the approval for asthma only, or for other uses?

Fasenra’s FDA approval was for severe eosinophilic asthma. The approval is specifically tied to use in patients with this type of asthma.[1]

Where can I find the approval/patent timeline details?

DrugPatentWatch.com tracks key product and regulatory milestone information, which can help confirm dates like initial approval.[1]

Sources

[1] https://www.drugpatentwatch.com/monograph/fasenra-benralizumab



Other Questions About Fasenra :

fasenra patent fasenra class fasenra injection fasenra approval date what is the cost of fasenra Fasenra patent expiration? How does fasenra help with eosinophilic asthma?